المؤلفون: Escamilla Prado, Esteban {et al.}

المصدر: Revista de Historia, Rev. Hist./Heredia, 30, julio/dic.1994, p.41-67, map, table 1012-9790

المؤلفون: Krotz, Esteban {et al.}

المساهمون: García Mora, Carlos., Krotz, Esteban.

المؤلفون: Krotz, Esteban {et al.}

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Pinazo MJ; Barcelona Institute for Global Health, ISGlobal-Hospital Clinic, Universitat de Barcelona, Barcelona, Spain; Drugs for Neglected Diseases initiative, Rio de Janeiro, Brazil; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Spain. Electronic address: mpinazo@dndi.org., Forsyth C; Drugs for Neglected Diseases initiative, Rio de Janeiro, Brazil., Losada I; Barcelona Institute for Global Health, ISGlobal-Hospital Clinic, Universitat de Barcelona, Barcelona, Spain., Esteban ET; Unidad de Patología Importada y Salud Internacional. Hospital Universitario La Paz, Madrid, Spain., García-Rodríguez M; Infectious Diseases Service, International Health Unit, Consorcio Hospital General Universitario de Valencia, Valencia, Spain., Villegas ML; Department of Internal Medicine, Hospital General de L'Hospitalet, Complex Hospitalari Universitari Moisès Broggi, Barcelona, Spain., Molina I; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Spain; Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain., Crespillo-Andújar C; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Spain; Unidad de Patología Importada y Salud Internacional. Hospital Universitario La Paz, Madrid, Spain; National Referral Unit for Tropical Diseases, Infectious Diseases Department, Ramón y Cajal University Hospital, IRYCIS, Madrid, Spain., Gállego M; Barcelona Institute for Global Health, ISGlobal-Hospital Clinic, Universitat de Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Spain; Parasitology Section, Department of Biology, Health, and Environment, Faculty of Pharmacy and Food Science, Universitat de Barcelona, Barcelona, Spain., Ballart C; Barcelona Institute for Global Health, ISGlobal-Hospital Clinic, Universitat de Barcelona, Barcelona, Spain; Parasitology Section, Department of Biology, Health, and Environment, Faculty of Pharmacy and Food Science, Universitat de Barcelona, Barcelona, Spain., Ramirez JC; Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas, CONICET-GCBA, Buenos Aires, Argentina., Aden T; Institute of Medical Microbiology, Immunology, and Parasitology, University Hospital Bonn, Germany., Hoerauf A; Institute of Medical Microbiology, Immunology, and Parasitology, University Hospital Bonn, Germany; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany., Pfarr K; Institute of Medical Microbiology, Immunology, and Parasitology, University Hospital Bonn, Germany; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany., Vaillant M; Competence Centre for Methodology and Statistics, Luxembourg Institute of Health, Strassen, Luxembourg., Marques T; Drugs for Neglected Diseases initiative, Rio de Janeiro, Brazil., Fernandes J; Drugs for Neglected Diseases initiative, Rio de Janeiro, Brazil., Blum B; Drugs for Neglected Diseases initiative, Rio de Janeiro, Brazil., Ribeiro I; Drugs for Neglected Diseases initiative, Rio de Janeiro, Brazil., Sosa-Estani S; Drugs for Neglected Diseases initiative, Rio de Janeiro, Brazil; Centro de Investigaciones en Epidemiología y Salud Pública (CIESP-CONICET), Buenos Aires, Argentina., Barreira F; Drugs for Neglected Diseases initiative, Rio de Janeiro, Brazil., Gascón J; Barcelona Institute for Global Health, ISGlobal-Hospital Clinic, Universitat de Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Spain.

مؤلفون مشاركون: FEXI-12 Study Team

المصدر: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Apr; Vol. 24 (4), pp. 395-403. Date of Electronic Publication: 2024 Jan 11.

نوع المنشور: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Chagas Disease*/drug therapy , Trypanosoma cruzi* , Nitroimidazoles*, Adult ; Humans ; Adolescent ; Young Adult ; Middle Aged ; Treatment Outcome ; Nifurtimox/adverse effects ; Double-Blind Method

المؤلفون: Díaz-Menéndez M; National Referral Unit for Imported Tropical Diseases. Department of Internal Medicine. Hospital Universitario La Paz-Carlos III, IdiPAZ, Madrid, Spain.; These authors contributed equally to the work., Esteban ET; National Referral Unit for Imported Tropical Diseases. Department of Internal Medicine. Hospital Universitario La Paz-Carlos III, IdiPAZ, Madrid, Spain.; These authors contributed equally to the work., Ujiie M; Vaccination Support Center, Disease Control and Prevention Center. National Center for Global Health and Medicine, Tokyo, Japan., Calleri G; Travel Medicine Unit. Amedeo di Savoia Hospital. ASL Città di Torino, Torino, Italy., Rothe C; LMU Hospital Centre, Division of Infectious Diseases and Tropical Medicine, Munich, Germany., Malvy D; Department of Infectious Diseases and Tropical Medicine, CHU de Bordeaux & INSERM 1219, University of Bordeaux, Bordeaux, France., Nicastri E; National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy., Bissinger AL; Institute for Tropical Medicine, Department of Internal Medicine, University Hospital Tübingen, Germany., Grandadam M; Arbovirus & Emerging viral diseases laboratory. Institut Pasteur du Laos, Vientiane, Laos., Alpern JD; Department of Travel and Tropical Medicine, HealthPartners; Department of Medicine, University of Minnesota, Minneapolis, United States., Gobbi F; Department of Infectious /Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy., Schlagenhauf P; University of Zürich Centre for Travel Medicine, WHO Collaborating Centre for Travellers' Health, Zürich, Switzerland., Duvignaud A; Department of Infectious Diseases and Tropical Medicine, CHU de Bordeaux & INSERM 1219, University of Bordeaux, Bordeaux, France., Javelle E; Laveran Military Teaching Hospital, Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France., Nakamoto T; Disease Control and Prevention Center, National Center for Global health and Medicine, Tokyo, Japan., Antinori S; Department of Biomedical and Clinical Sciences 'L Sacco', University of Milan. Tropical Medicine Unit, ASST Fatebenefratelli Sacco, Milan, Italy., Hamer DH; Department of Global Health and Boston University School of Public Health and Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, United States.

المصدر: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2020 Jan; Vol. 25 (1).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: European Centre for Disease Prevention and Control (ECDC) Country of Publication: Sweden NLM ID: 100887452 Publication Model: Print Cited Medium: Internet ISSN: 1560-7917 (Electronic) Linking ISSN: 1025496X NLM ISO Abbreviation: Euro Surveill Subsets: MEDLINE

مواضيع طبية MeSH: Travel*, Arthralgia/*etiology , Chikungunya Fever/*diagnosis , Chikungunya virus/*isolation & purification , Fever/*etiology, Adult ; Aged ; Chikungunya Fever/blood ; Chikungunya Fever/epidemiology ; Chikungunya virus/genetics ; Disease Outbreaks ; Exanthema/etiology ; Female ; Humans ; Male ; Middle Aged ; Mosquito Vectors/virology ; Myanmar/epidemiology ; Sentinel Surveillance